Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission

被引:9
|
作者
Ninomiya, Toshifumi [1 ,2 ]
Otsubo, Kohei [1 ]
Hoshino, Teppei [3 ]
Shimokawa, Mototsugu [4 ]
Nakazawa, Megumi [2 ]
Sato, Yoriko [2 ]
Mikumo, Hironori [2 ]
Kawakami, Satoru [2 ,5 ]
Mizusaki, Shun [1 ,2 ]
Mori, Yusuke [3 ]
Arimura, Hidenobu [1 ]
Tsuchiya-Kawano, Yuko [1 ]
Inoue, Koji [1 ]
Uchida, Yujiro [2 ]
Nakanishi, Yoichi [6 ]
机构
[1] Kitakyushu Municipal Med Ctr, Dept Resp Med, Kokurakita Ku, 2-1-1 Bashaku, Kitakyushu, Fukuoka 8020077, Japan
[2] Kitakyushu Municipal Med Ctr, Dept Gen Internal Med, Kokurakita Ku, 2-1-1 Bashaku, Kitakyushu, Fukuoka 8020077, Japan
[3] Kitakyushu City Yahata Hosp, Dept Internal Med, Yahatahigashi Ku, 2-6-2 Ogura, Kitakyushu, Fukuoka 8058534, Japan
[4] Yamaguchi Univ, Dept Biostat, Grad Sch Med, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan
[5] JCHO Kyushu Hosp, Dept Resp Med, Yahatanishi Ku, 1-8-1 Kishinoura, Kitakyushu, Fukuoka 8068501, Japan
[6] Kitakyushu City Hosp Org, Kokurakita Ku, 1-35 Furusenba Machi, Kitakyushu, Fukuoka 8020082, Japan
关键词
COVID-19; Risk factors; Disease progression;
D O I
10.1186/s12879-021-06574-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Although the risk factors for coronavirus disease 2019 (COVID-19) mortality have been identified, there is limited information about the risk factors for disease progression after hospitalization among Japanese patients with COVID-19 exhibiting no or mild symptoms. Methods All 302 consecutive patients who were admitted to our institutions and diagnosed with COVID-19 between March and December 2020 were retrospectively assessed. Ultimately, 210 adult patients exhibiting no or mild symptoms on admission were included in the analysis. They were categorized into the stable (no oxygen needed) and worsened (oxygen needed) groups, and their characteristics and laboratory data were compared. Results Among 210 patients, 49 progressed to a severe disease stage, whereas 161 did not. The mean patient age was 52.14 years, and 126 (60.0%) patients were male. The mean body mass index (BMI) was 23.0 kg/m(2), and 71 patients were overweight (BMI >= 25 kg/m(2)). Multivariate logistic analysis showed that old age, overweight, diabetes mellitus (DM), and high serum ferritin levels were independent risk factors for disease progression. Conclusions Clinicians should closely observe patients with COVID-19, especially those with risk factors such as old age, overweight, DM, and high serum ferritin levels, regardless of whether they have no or mild symptoms.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission
    Toshifumi Ninomiya
    Kohei Otsubo
    Teppei Hoshino
    Mototsugu Shimokawa
    Megumi Nakazawa
    Yoriko Sato
    Hironori Mikumo
    Satoru Kawakami
    Shun Mizusaki
    Yusuke Mori
    Hidenobu Arimura
    Yuko Tsuchiya-Kawano
    Koji Inoue
    Yujiro Uchida
    Yoichi Nakanishi
    BMC Infectious Diseases, 21
  • [2] ICU admission of COVID-19 patients: Identification of risk factors
    Fouad, Shaimaa H.
    Allam, Mohamed Farouk
    Ibrahim, Sara
    Okba, Ahmed Ashraf
    Roman, Sylvia W.
    Hosny, Amr
    Moneer, Mayada
    EGYPTIAN JOURNAL OF ANAESTHESIA, 2021, 37 (01): : 202 - 207
  • [3] Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
    Terada, Mari
    Ohtsu, Hiroshi
    Saito, Sho
    Hayakawa, Kayoko
    Tsuzuki, Shinya
    Asai, Yusuke
    Matsunaga, Nobuaki
    Kutsuna, Satoshi
    Sugiura, Wataru
    Ohmagari, Norio
    BMJ OPEN, 2021, 11 (06):
  • [4] Risk factors for the deterioration of patients with mild COVID-19 admitted to a COVID-19 community treatment center
    Lee, Seung Yeon
    Song, Kyoung Jun
    Lim, Chun Soo
    Chai, Young Jun
    Lee, Sun Young
    Lee, Stephen Gyung Won
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (06): : 377 - 385
  • [5] Hospital Admission Factors Independently Affecting the Risk of Mortality of COVID-19 Patients
    Paciorek, Marcin
    Bienkowski, Carlo
    Kowalska, Justyna Dominika
    Skrzat-Klapaczynska, Agata
    Bednarska, Agnieszka
    Krogulec, Dominika
    Cholewinska, Grazyna
    Kowalski, Jacek
    Podlasin, Regina
    Ropelewska-Lacka, Katarzyna
    Wasilewski, Piotr
    Boros, Piotr W.
    Martusiewicz-Boros, Magdalena M.
    Pulik, Piotr
    Pihowicz, Andrzej
    Horban, Andrzej
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [6] Risk factors associated with the progression of COVID-19 in elderly diabetes patients
    Zhang, Pei
    Wang, Maomao
    Wang, Yang
    Wang, Yifei
    Li, Ting
    Zeng, Jing
    Wang, Laixing
    Li, Chunlin
    Gong, Yanping
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 171
  • [7] COVID-19 in Elderly Patients: Risk Factors for Disease Severity
    Korkmaz, Pinar
    Ozatag, Duru Mistanoglu
    Aslan, Halil
    Toka, Onur
    Gulcan, Aynur
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2022, 4 (01): : 7 - 17
  • [8] Risk Factors of COVID-19 Patients
    Ouchetto, Ouail
    Drissi Bourhanbour, Asmaa
    DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS, 2022, 16 (04) : 1300 - 1302
  • [9] Prediction of COVID-19 Patients at High Risk of Progression to Severe Disease
    Dai, Zhenyu
    Zeng, Dong
    Cui, Dawei
    Wang, Dawei
    Feng, Yanling
    Shi, Yuhan
    Zhao, Liangping
    Xu, Jingjing
    Guo, Wenjuan
    Yang, Yuexiang
    Zhao, Xinguo
    Li, Duoduo
    Zheng, Ye
    Wang, Ao
    Wu, Minmin
    Song, Shu
    Lu, Hongzhou
    FRONTIERS IN PUBLIC HEALTH, 2020, 8
  • [10] Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19
    Falcone, Marco
    Suardi, Lorenzo Roberto
    Tiseo, Giusy
    Barbieri, Chiara
    Giusti, Lisa
    Galfo, Valentina
    Forniti, Arianna
    Caroselli, Claudio
    Della Sala, Leonardo
    Tempini, Sara
    Okoye, Chukwuma
    Monzani, Fabio
    Menichetti, Francesco
    CLINICAL THERAPEUTICS, 2022, 44 (03) : 364 - 373